Abstract
Pregnancy-associated plasma protein-A (PAPP-A), is gaining interest as a possible biomarker and contributory factor to female cardiovascular health issues. This review article highlights the increasing amount of research connecting PAPP-A to heart failure and other cardiovascular concerns in females. PAPP-A levels have been found to be higher in women with heart failure and also been linked to the development and advancement of cardiovascular risks (atherosclerosis and coronary artery disease) in women. Improvements in risk assessment, early identification, and customized therapies for cardiovascular illnesses in women may be made possible by developments in this sector.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
